In a press release Thursday, graphics chip specialist NVIDIA (NASDAQ: NVDA ) announced it will return an additional $1 billion to shareholders this fiscal year in the form of dividends and share buybacks.
If this seems like a lot for a company whose entire market capitalization is under $8 billion... well, that's because it is.
Is $1 billion overkill?
For those of you keeping track, however, you know this is pocket change for NVIDIA, which had $3.73 billion in cash and no debt on its balance sheet at the end of its most recent quarter. In fact, that's one reason I singled out NVIDIA just a few days ago as one of three solid dividend stocks�any investor could be happy to own.
Thursday's announcement, however, ups the ante, as it represents a massive vote of confidence that the puzzle pieces are in place for their long-term oriented efforts to succeed. As CEO Jen-Hsun Huang elaborated,�"NVIDIA's�strategies are gaining traction in the market and make us confident in our ability to continue generating cash."�
Best US Companies To Watch In Right Now: Trans World Entertainment Corp.(TWMC)
Trans World Entertainment Corporation, through its subsidiaries, operates as a specialty retailer of entertainment software products, including music, video, video games, and other related products through its retail stores and e-commerce sites in the United States. The company?s other related products include electronics, accessories, and trend items. As of January 29, 2011, it operated 376 mall-based stores under the For Your Entertainment (f.y.e.), Suncoast Motion Pictures, and Saturday Matinee brand names in regional shopping malls; 84 freestanding stores under the f.y.e. brand name; and 3 retail Websites, including fye.com, wherehouse.com, and secondspin.com. The company operates retail stores in the United States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands. Trans World Entertainment Corporation was founded in 1972 and is headquartered in Albany, New York.
Advisors' Opinion:- [By Tim Melvin]
The safe and cheap undervalued stocks will go right up, but your chances of being destroyed when the party is over are diminished. Stocks like Richardson Electronics (RELL) and Transworld Entertainment (TWMC) have the ability to go up as the market bubbles higher but their asset value will act as sort of a floor in a decline.
Top 5 Gas Utility Stocks To Own Right Now: Entest Biomedical Inc (ENTB)
Entest BioMedical, Inc. (Entest), incorporated on September 24, 2008, is a development-stage company. During the fiscal year ended August 31, 2012, the Company�� business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is focusing its research and development efforts toward the development and commercialization of the ImenVax family of canine cancer vaccines. ImenVax I is a therapeutic for canine cancer, which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. ImenVax II, which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses.
ImenVax
The Company is conducting a ten dog safety study to Evaluate ImenVax I for the Treatment of Canine Oral Melanoma. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.
ImenVax II
The Company intends to include adjuvant cytokine along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line.
ImenVax III
ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax III is intended to treat existing tumors through stimulation of immune responses to kill tumor cells directly; indirectly kill tumor cells by cutting off the tumor blood supply, and block the ability of the tumor to suppress the immune system.
ENT-576
ENT-57 is a therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD), such therapy consists of extracting a therapeutic number of cells from a tissue containing in part a stem cell population; processing sai! d population of cells derived from said tissue so as to concentrate said stem cell population; systemic re-administration of said cell population into the same patient, and exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration.
Advisors' Opinion:- [By Bryan Murphy]
The so-called fundamentals, frankly, don't really matter for Entest BioMedical Inc. (OTCMKTS:ENTB) or Gevo, Inc. (NASDAQ:GEVO). Oh, both GEVO and ENTB are generating sales, but both are consistently taking losses. That's ok though, as for both companies right now, profits aren't really the point - it's the pipeline that matters.
- [By Peter Graham]
Small cap mining stocks US Tungsten Corp (OTCMKTS: USTU) and LKA Gold Inc (OTCMKTS: LKAI) along with biotech Entest BioMedical Inc (OTCMKTS: ENTB) have been getting some attention lately in various investment newsletters with at least one of these stocks being the subject of paid promotions while another could soon be the subject of an investor relations campaign. But will any of these small cap stocks be winners for investors or traders? Here is a quick reality check:
Top 5 Gas Utility Stocks To Own Right Now: Gas Natural Inc. (EGAS)
Gas Natural Inc. engages in the distribution and sale of natural gas to residential, commercial, and industrial customers in Montana, Wyoming, North Carolina, and Maine. The company distributes approximately 30 billion cubic feet of natural gas to approximately 63,500 customers through regulated utilities operating in Montana, Wyoming, Maine, North Carolina, Ohio, and Pennsylvania. It also markets approximately 1.3 billion cubic feet of natural gas to commercial and industrial customers in Montana and Wyoming, and manages midstream supply and production assets for transportation customers and utilities. In addition, the company owns a 48% working interest in 160 natural gas producing wells and gas gathering assets. Further, it owns the Shoshone interstate and the Glacier gathering natural gas pipelines located in Montana and Wyoming. The company was formerly known as Energy, Inc. and changed its name to Gas Natural Inc. in July 2010. Gas Natural Inc. was founded in 1909 an d is headquartered in Great Falls, Montana.
Advisors' Opinion:- [By David Dittman]
Gas Natural Inc (NYSE: EGAS) distributes and sells natural gas to approximately 73,000 residential, commercial and industrial customers through regulated utilities operating in Montana, Wyoming, Ohio, Pennsylvania, Maine, North Carolina and Kentucky.
Top 5 Gas Utility Stocks To Own Right Now: Ram Resources Ltd (RMR)
Ram Resources Limited is an Australia-based company. The Company is engaged in exploration of mineral properties in Greenland and Western Australia. The Company�� Motzfeld Project is located in South Greenland, some 24 kilometers from the town of Narsarsuaq and comprises exploration licences 2010/46 and 2011/24. The Company holds 51% interest in the Motzfeldt project. The Romney (EL 2010/46) located in the Lejrelev Valley about 3.5 kilometers to the west of the Aries prospect. The Merino forms a steep-sided ridge at the north-eastern end of this valley, about 2.5 kilometers to the north-north-west of Aries. The Company�� Voskop Prospect is located within Exploration Licence 2011/24 in the Storeelv Valley about 7 kilometers to the northwest of the Company�� Aries target. The Drysdale Prospect is located on top of a broad ridge about 7.5 kilometers southeast of Aries and at an elevation of about 1,600 meter. Advisors' Opinion:- [By Chris DeMuth Jr.]
To use a recent REIT example, take CommonWealth REIT. This is a large well established REIT that is valued in the market with one of the lowest multiples of FFO in the industry. The reason the company trades at a multiple roughly half its competitors, in my opinion, is the poorly aligned management incentive structure. The management of CommonWealth is contracted to an external management firm, Reit Management Research (RMR). Many of the trustees of CommonWeath are owners of RMR and serve on both boards. RMR is primarily compensated by growing CWH's assets which are under RMR's management, not on stock price, FFO, or anything else that is closely aligned to generating shareholder returns. This has the perverse effect of motivating them to issue lots of equity and buy lots of buildings irrespective of the value add to CommonWealth shareholders. Neither the management company nor its employees have a significant amount of their income based on the performance of CommonWealth's stock price. This has resulted in an activist, Corvex Capital, buying a significant position in the company and taking action to replace the board and the management team. The proxy advisory firm, ISS, has sided with the activist and recommended that shareholders vote out the current trustees. ISS notes, "Between 2007-2012 …while the CommonWealth management team increased assets by 198% of period-ending market cap - driving a significant increase in fees payable to management - Commonwealth's share price - the measure of value appreciation for shareholders - fell by 68%." This is the poster child of misaligned management incentives.
No comments:
Post a Comment